Narrative review / 2011
A review summarizes human pharmacokinetic and pharmacodynamic data for resveratrol, noting a lack of clinical evidence and conflicting capsule versus food data.
This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.
- Study type
- Narrative review
- Who was studied
- Published human pharmacokinetic and pharmacodynamic data
- What was measured
- Human pharmacokinetic and pharmacodynamic data of resveratrol
THE PAPER
Resveratrol--pills to replace a healthy diet?
Chachay VS, Kirkpatrick CM, Hickman IJ, Ferguson M, Prins JB, Martin JH. Br J Clin Pharmacol, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.